Prucalopride for constipation

Michael Camilleri, Annemie Deiteren

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Importance of the field: Chronic constipation has a high prevalence, and current medical and pharmacological therapies do not restore normal bowel function in all patients. Areas covered in the review: A PubMed search (1965 - 2009) using the following terms alone or in combination: prucalopride, 5-HT 4, R093877, safety, toxicity, pharmacokinetics, pharmacodynamics, transit, cardiac, hERG, arrhythmia, potassium current, elderly. What the reader will gain: Understanding of the mechanisms of action, safety, efficacy and indications for prucalopride in patients with chronic constipation. Take home message: Prucalopride is an efficacious and generally safe, new therapeutic option in the management of chronic constipation.

Original languageEnglish (US)
Pages (from-to)451-461
Number of pages11
JournalExpert Opinion on Pharmacotherapy
Volume11
Issue number3
DOIs
StatePublished - Feb 2010

Fingerprint

prucalopride
Constipation
Safety
PubMed
Cardiac Arrhythmias
Serotonin
Potassium
Pharmacokinetics
Pharmacology
Therapeutics

Keywords

  • 5-HT receptor
  • Efficacy
  • Enterokinetic
  • Pharmacodynamics
  • Pharmacokinetics
  • Prokinetic
  • R093887
  • R108512
  • Safety
  • Serotonin agonist

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Prucalopride for constipation. / Camilleri, Michael; Deiteren, Annemie.

In: Expert Opinion on Pharmacotherapy, Vol. 11, No. 3, 02.2010, p. 451-461.

Research output: Contribution to journalArticle

Camilleri, Michael ; Deiteren, Annemie. / Prucalopride for constipation. In: Expert Opinion on Pharmacotherapy. 2010 ; Vol. 11, No. 3. pp. 451-461.
@article{589bade9232a46e6a0fc11f8024fba66,
title = "Prucalopride for constipation",
abstract = "Importance of the field: Chronic constipation has a high prevalence, and current medical and pharmacological therapies do not restore normal bowel function in all patients. Areas covered in the review: A PubMed search (1965 - 2009) using the following terms alone or in combination: prucalopride, 5-HT 4, R093877, safety, toxicity, pharmacokinetics, pharmacodynamics, transit, cardiac, hERG, arrhythmia, potassium current, elderly. What the reader will gain: Understanding of the mechanisms of action, safety, efficacy and indications for prucalopride in patients with chronic constipation. Take home message: Prucalopride is an efficacious and generally safe, new therapeutic option in the management of chronic constipation.",
keywords = "5-HT receptor, Efficacy, Enterokinetic, Pharmacodynamics, Pharmacokinetics, Prokinetic, R093887, R108512, Safety, Serotonin agonist",
author = "Michael Camilleri and Annemie Deiteren",
year = "2010",
month = "2",
doi = "10.1517/14656560903567057",
language = "English (US)",
volume = "11",
pages = "451--461",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Prucalopride for constipation

AU - Camilleri, Michael

AU - Deiteren, Annemie

PY - 2010/2

Y1 - 2010/2

N2 - Importance of the field: Chronic constipation has a high prevalence, and current medical and pharmacological therapies do not restore normal bowel function in all patients. Areas covered in the review: A PubMed search (1965 - 2009) using the following terms alone or in combination: prucalopride, 5-HT 4, R093877, safety, toxicity, pharmacokinetics, pharmacodynamics, transit, cardiac, hERG, arrhythmia, potassium current, elderly. What the reader will gain: Understanding of the mechanisms of action, safety, efficacy and indications for prucalopride in patients with chronic constipation. Take home message: Prucalopride is an efficacious and generally safe, new therapeutic option in the management of chronic constipation.

AB - Importance of the field: Chronic constipation has a high prevalence, and current medical and pharmacological therapies do not restore normal bowel function in all patients. Areas covered in the review: A PubMed search (1965 - 2009) using the following terms alone or in combination: prucalopride, 5-HT 4, R093877, safety, toxicity, pharmacokinetics, pharmacodynamics, transit, cardiac, hERG, arrhythmia, potassium current, elderly. What the reader will gain: Understanding of the mechanisms of action, safety, efficacy and indications for prucalopride in patients with chronic constipation. Take home message: Prucalopride is an efficacious and generally safe, new therapeutic option in the management of chronic constipation.

KW - 5-HT receptor

KW - Efficacy

KW - Enterokinetic

KW - Pharmacodynamics

KW - Pharmacokinetics

KW - Prokinetic

KW - R093887

KW - R108512

KW - Safety

KW - Serotonin agonist

UR - http://www.scopus.com/inward/record.url?scp=76449107222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76449107222&partnerID=8YFLogxK

U2 - 10.1517/14656560903567057

DO - 10.1517/14656560903567057

M3 - Article

C2 - 20102308

AN - SCOPUS:76449107222

VL - 11

SP - 451

EP - 461

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 3

ER -